Carmignac Gestion Exact Sciences Corp Transaction History

Carmignac Gestion

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$55.75 - $92.75 $52.4 Million - $87.2 Million	-939,936 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$37.9 - $104.44 $2.5 Million - $6.88 Million	65,921 Added 7.54%	939,936 $54.5 Million
Q4 2019 Feb 13, 2020	BUY	$77.66 - $99.74 $67.9 Million - $87.2 Million	874,015 New	874,015 $80.8 Million

674

163M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Carmignac Gestion, based on Form 13F filings with the SEC.

Stay updated on Carmignac Gestion with notifications on news.